Investor Presentaiton

Numerous levers to drive long-term growth $ $ Strong Base Business with unrecognized durability Increasingly de-risked New Product Portfolio Expanding registrational pipeline from 6 to 12 new assets over next 18 months Robust early pipeline with 30+ assets & opportunity to deliver ~10 INDs a year Increased R&D productivity Strategic optionality from Business Development Bristol Myers Squibb™ Not for Product Promotional Use 6

View entire presentation